Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Oct;104(4):655-663.
doi: 10.1002/ccd.31207. Epub 2024 Aug 29.

Intravascular lithotripsy in heavily calcified chronic total occlusion: procedural and one-year clinical outcomes

Federico Oliveri  1 , Martijn J H van Oort  1 , Ibtihal Al Amri  1 , Brian O Bingen  1 , Bimmer E Claessen  2 , Aukelien C Dimitriu-Leen  3 , Joelle Kefer  4 , Hany Girgis  5 , Tessel Vossenberg  6 , Frank van der  1 , J Wouter Jukema  1   7 , Jose M Montero-Cabezas  1
Affiliations
Observational Study

Intravascular lithotripsy in heavily calcified chronic total occlusion: procedural and one-year clinical outcomes

Federico Oliveri et al. Catheter Cardiovasc Interv. 2024 Oct.

Erratum in

Abstract

Background: Calcification within chronic total occlusions (CTO) is strongly associated with worse outcomes. Despite the excellent success and safety of intravascular lithotripsy (IVL) in heavily calcified lesions, evidence in CTO remains scarce.

Aim: This study aimed to evaluate the procedural and long-term clinical outcomes of IVL in heavily calcified CTO.

Methods: Patients who underwent IVL between 2019 and 2024 from an ongoing prospective multicenter registry were eligible for inclusion. Patients were therefore classified in CTO and non-CTO groups. The efficacy and safety endpoints of CTO percutaneous coronary interventions were defined according to the CTO-ARC consensus. In-hospital major adverse cardiovascular events (MACE) included cardiac death, nonfatal myocardial infarction and target lesion revascularization (TVR).

Results: A total of 404 patients underwent IVL, of which the treated lesion was a CTO in 33 (8.2%). The mean J-CTO score was 2.3 ± 1.1. Device success showed no significant difference between CTO and non-CTO groups (100% vs 98.4%; p = 0.35). Comparable technical success with residual stenosis <30% was observed in both groups (90.1% in CTO vs 89.2% in non-CTO, p = 0.83). The incidence of MACE was similar across groups during hospital stays (CTO 6.0% vs. non-CTO 1.9%, p = 0.12), at 30-day (CTO 9.1% vs. non-CTO 3.0%, p = 0.07), and at 12-month follow-up (CTO 9.1% vs. non-CTO 7.3%, p = 0.70).

Conclusion: IVL provides high procedural success and consistent clinical outcomes in both CTO and non-CTO cases, reinforcing its role in managing heavily calcified coronary lesions.

Keywords: IVL and CTO; chronic total occlusion; intracoronary lithotripsy; intracoronary lithotripsy and chronic total occlusion.

PubMed Disclaimer

References

REFERENCES

    1. Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO‐ARC consensus recommendations. Circulation. 2021;143(5):479–500.
    1. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions. J Am Coll Cardiol. 2012;59(11):991–997.
    1. Azzalini L, Jolicoeur EM, Pighi M, et al. Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion. Am J Cardiol. 2016;118:1128–1135.
    1. Azzalini L, Carlino M, Bellini B, et al. Long‐term outcomes of chronic total occlusion recanalization versus percutaneous coronary intervention for complex non‐occlusive coronary artery disease. Am J Cardiol. 2020;125(2):182–188.
    1. Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions. JACC: Cardiovasc Interven. 2013;6(2):128–136.

Publication types

MeSH terms

LinkOut - more resources